Could male circumcision reduce HIV incidence in the UK?*
Authors:
Open Access
- 8 July 2008
- journal article
- Published by Wiley in HIV Medicine
- Vol. 9 (6) , 329-331
Abstract
We consider the public health relevance of three recent African clinical trials showing male circumcision (MC) to reduce female‐to‐male transmission of HIV for the UK. Although heterosexually acquired HIV infections now account for the majority of new diagnoses in the UK each year, it is important to note that when considering the public health relevance of MC for the UK a large majority of these infections are acquired abroad. Men who have sex with men (MSM) remain those most at risk of acquiring their HIV infection in the UK. The efficacy and effectiveness of MC among MSM and in particular its protective role in unprotected anal intercourse between men remains unknown. Any future consideration of the role of MC in reducing HIV incidence in the UK should not be at the expense of weakening existing effective interventions.Keywords
This publication has 6 references indexed in Scilit:
- Male circumcision for the prevention of heterosexually acquired HIV infection: a meta‐analysis of randomized trials involving 11 050 men*HIV Medicine, 2008
- Circumcision Status and HIV Infection Among Black and Latino Men Who Have Sex With Men in 3 US CitiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trialThe Lancet, 2007
- Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 TrialPLOS Medicine, 2005
- Sexual Risk, Nitrite Inhalant Use, and Lack of Circumcision Associated With HIV Seroconversion in Men Who Have Sex With Men in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Per-Contact Risk of Human Immunodificiency Virus Tramnsmision between Male Sexual PartnersAmerican Journal of Epidemiology, 1999